These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 11520415
1. Primary refractoriness to platelet transfusion caused by Nak(a) antibody alone. Fujino H, Ohta K, Taniue J, Nagao N, Hino M, Yamane T, Koh KR, Takeoka Y, Hirose A, Aoyama Y, Nakamae H, Terada Y, Takubo T, Tatsumi N. Vox Sang; 2001 Jul; 81(1):42-4. PubMed ID: 11520415 [Abstract] [Full Text] [Related]
2. Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies. Xu X, Ye X, Xia W, Liu J, Ding H, Deng J, Chen Y, Shao Y, Wang J, Fu Y, Santoso S. Thromb Haemost; 2013 Dec; 110(6):1199-206. PubMed ID: 23966019 [Abstract] [Full Text] [Related]
3. Platelet transfusion refractoriness associated with HPA-1a (Pl(A1)) alloantibody without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions. Pappalardo PA, Secord AR, Quitevis P, Haimowitz MD, Goldfinger D. Transfusion; 2001 Aug; 41(8):984-7. PubMed ID: 11493728 [Abstract] [Full Text] [Related]
4. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness. Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S. Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675 [Abstract] [Full Text] [Related]
6. [Anti-CD36 Mediated Platelet Transfusion Refractoriness and Related Cases After Stem Cell Transplantation]. Zhou Y, Li LL, Zhong ZL, Liu XJ, Liu JL, Shen WD, Wu GG. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):541-546. PubMed ID: 29665929 [Abstract] [Full Text] [Related]
7. Role of anti-Nak(a) antibody, monocytes and platelets in the development of transfusion-related acute lung injury. Nakajima F, Nishimura M, Hashimoto S, Okazaki H, Tadokoro K. Vox Sang; 2008 Nov; 95(4):318-23. PubMed ID: 19138262 [Abstract] [Full Text] [Related]
9. [Study of the platelet GP specific antibodies and HLA antibodies expression in platelet transfusion refractoriness patients]. Xia WJ, Ye X, Deng J, Chen YK, Xu XZ, Ding HQ, Luo GP, Fu YS. Zhonghua Xue Ye Xue Za Zhi; 2010 Sep; 31(9):594-8. PubMed ID: 21122318 [Abstract] [Full Text] [Related]
11. Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines. Lin M, Xu X, Lee HL, Liang DC, Santoso S. Transfusion; 2018 Jan; 58(1):189-195. PubMed ID: 29030871 [Abstract] [Full Text] [Related]
12. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness]. Basire A, Picard C. Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423 [Abstract] [Full Text] [Related]
13. Recognition and management of antibodies to human platelet antigens in platelet transfusion-refractory patients. Vassallo RR. Immunohematology; 2009 Nov; 25(3):119-24. PubMed ID: 20406018 [Abstract] [Full Text] [Related]
14. Two cases of platelet transfusion refractoriness associated with anti-CD36. Saw CL, Szykoluk H, Curtis BR, Zelcer S, Eckert K, Forrest D, Nickerson P, Petraszko T, Goldman M. Transfusion; 2010 Dec; 50(12):2638-42. PubMed ID: 20561295 [Abstract] [Full Text] [Related]
16. A structural/functional domain on human CD36 is involved in the binding of anti-Nak(a) antibodies. Daviet L, Morel-Kopp MC, Kaplan C, McGregor JL. Thromb Haemost; 1995 Mar; 73(3):543-5. PubMed ID: 7545324 [Abstract] [Full Text] [Related]
17. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children]. Pereira J, Bronfman L, Bertín P, Marzouka E, Hidalgo P, Amaya S, Mezzano D. Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051 [Abstract] [Full Text] [Related]
20. Antibodies to human platelet antigens form a significant proportion of platelet antibodies detected in Indian patients with refractoriness to platelet transfusions. Abraham AS, Chacko MP, Fouzia NA, Srivastava A, Daniel D. Transfus Med; 2018 Oct; 28(5):392-397. PubMed ID: 29460307 [Abstract] [Full Text] [Related] Page: [Next] [New Search]